Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Bioorg Med Chem. 2019 May 9;27(13):2972–2977. doi: 10.1016/j.bmc.2019.05.009

Figure 3:

Figure 3:

SPR competition assay. Competition with excess tRNA ablates signal from neomycin binding (a) but has little impact on binding of compound 6 (b). Two replicate injections are shown for each condition.